PDK2 and cancer: Moreover, we found that miR-146b-3p is a key inhibitor to target PDK2 to suppress Akt signaling pathway, Previous findings showed that cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signaling pathway [17].